葛纪弯，女，博士，中国医学科学院病原生物学研究所助理教授，副研究员，博士研究生导师。2013年获山东大学学士学位，2019年获清华大学理学博士学位，之后在清华大学从事博士后研究，期间获2021年度清华大学优秀博士后称号，重要医学进展（2020）以及北京市高精尖创新中心卓越学者称号，2023年以助理教授的身份加入中国医学科学院病原生物学研究所，入选2023年科睿唯安“中国高被引学者”。 近五年以第一/通讯作者在《Nature》、《Immunity》、《Nature Communications》、《Cell Research》、《Cell Discovery》、《Structure》、《Cell host & Microbe》等国际高水平杂志共发表SCI论文12篇；近5年主持国家级项目1项（国家自然科学基金青年项目，已结题）；一项北京市高创计划青年人才托举工程；主持院所级在研项目2项，含500万元引进人才启动基科费项目、90万元科技人才支持专项。负责开展1门研究生课程《微生物结构生物学导论》。

通过结构生物学技术手段探究病原与宿主相互作用的结构机理

邮箱：gejiwan@ipbcams.ac.cn

1. Cai X#, Fan M#, Zhai Y#, Luo W#, Liu S, Lv K, Zhao M, Liu L, Zhou S, Xu M, He B, Sun Y, Zhao R, Zhu X, Kuang Y, Lu H, Yue X, Li K, Zhang Y, Yuan L, Zhou N, Ye F, Liang H, Chen Y, Zheng M, Hong Z, Wang D, Zhang Z, Shu Y.-L*, Ge J*, Chen Y*.Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B viruses. Cell Host & Microbe. 2026, 34(5): 860-872.E5. (IF=18.7)
2. . Qu, Y.#, Tai, W.#, Ma, E.#, Jiang, Q.#, Fan, M., Xiao, W., Tian, C., Liu, Y., Liu, J., Wang, X., Ge, J.*, Cheng, G.* (2025). Generation and characterization of neutralizing antibodies against M1R and B6R proteins of monkeypox virus. Nature Communications 16 (1):3100. (IF=15.7) 
3. Lv, K.#, Li, X.#, Zhu, X.#, Cai, J.-P.#, Liu, S.#, Sun, Y., Liu, L., Cai, X., Cao, R., Xu, M., Yue, X., Zhai, Y., Luo, W., Lu, H., Li, R., Mai, H., Deng, L., Ye, F., Chen, S., Shi, M., Luo, H., Wang, X., Yuan, S.*, Shu, Y.*, Ge, J.*, Chen, Y.-Q.* (2025). Broad neuraminidase antibodies confer protection against seasonal and avian influenza viruses. Nature Communications 16 (1):7103. (IF=15.7) 
4. Yang, X.#, Guo, L.#, Duan, H.#, Fan, M.#, Xu, F., Chi, X., Pan, S., Liu, X., Zhang, X., Gao, P., Zhang, F., Wang, X., Guo, F., Ge, J.*, Ren, L.*, Yang, W.* (2025). Identification of neutralizing nanobodies protecting against poxvirus infection. Cell Discovery 10 (1):771. (IF=12.5)
5. Lan, J.#, He, X.#, Ren, Y.#, Wang, Z.#, Zhou, H., Fan, S., Zhu, C., Liu, D., Shao, B., Liu, T.-Y., Wang, Q., Zhang, L.*, Ge, J.*, Wang, T.*, Wang, X.* (2022). Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction. Cell Research (2022) 32 (6):593–595. (IF=41.8)
6. Ge, J.#, Wang, R.#, Ju, B.#, Zhang, Q.#, Tian, Y., Shan, S., Cheng, L., Zhou, B., Song, S., Zhao, J., Wang, H., Shi, X., Ding, Q., Liu, L., Sun, J., Zhao, J., Zhang, S., Zhang, Z.*, Wang, X.*, Zhang, L.* (2021). Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry. Nature Communications 12 (1):250. (IF=23.2)
7. Wang, R.#, Zhang, Q.#, Ge, J.#, Ren, W., Zhang, R., Lan, J., Ju, B., Su, B., Yu, F., Chen, P., Liao, H., Feng, Y., Li, X., Shi, X., Zhang, Z., Zhang, F., Ding, Q., Zhang, T.*, Wang, X.*, Zhang, L*. (2021). Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity 54, 1611-1621. (IF=46)
8. Zhang Q#, Ju B#, Ge J#, Chan JF#, Cheng L#, Wang R#, Huang W#, Fang M, Chen P, Zhou B, Song S, Shan S, Yan B, Zhang S, Ge X, Yu J, Zhao J, Wang H, Liu L, Lv Q, Fu L, Shi X, Yuen KY, Liu L, Wang Y*, Chen Z*, Zhang L*, Wang X*, Zhang Z*. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nature Communications 2021 Jul 9;12(1):4210. (IF=23.2)
9. Lan, J.#, Ge, J.#, Yu, J.#, Shan, S.#, Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L.*, Wang, X*. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215-220. (IF=42，ESI).
10. Ju, B.#, Zhang, Q.#, Ge, J.#, Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., Tang, X., Yu, J., Lan, J., Yuan, J., Wang, H., Zhao, J., Zhang, S., Wang, Y., Shi, X., Liu, L., Zhao, J., Wang, X. *, Zhang, Z. *, Zhang, L.* (2020). Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584 (7821):115–119. (IF=42，ESI).